719276-42-3

Basic information

• Product Name: Oxirane, [(3-methoxyphenoxy)methyl]-, (2R)- (9CI)
• Synonyms: Oxirane, [(3-methoxyphenoxy)methyl]-, (2R)- (9CI)
• CAS NO: 719276-42-3
• Molecular Formula: C10H12O3
• Molecular Weight: 180.20048
• Product Categories: METHOXY
• Mol File: 719276-42-3.mol
• Article Data: 14

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Oxirane, [(3-methoxyphenoxy)methyl]-, (2R)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Oxirane, [(3-methoxyphenoxy)methyl]-, (2R)- (9CI)(719276-42-3)
• EPA Substance Registry System: Oxirane, [(3-methoxyphenoxy)methyl]-, (2R)- (9CI)(719276-42-3)

Safety Data

• Hazardous Substances Data: 719276-42-3(Hazardous Substances Data)

Upstream product

• 150-19-6 O-methylresorcine 
• 106-89-8 epichlorohydrin 
• 3132-64-7 1,2-Epoxy-3-bromopropane 
• 2210-75-5 1-(m-methoxy-phenoxy)-2,3-epoxy-propane 
• 67843-74-7 (S)-epichlorohydrin 

Downstream Products

• 53730-57-7 N-{2-[2-Hydroxy-3-(3-methoxy-phenoxy)-propylamino]-propyl}-2-phenyl-acetamide 
• 250778-97-3 (S)-glycidyl 3-methoxyphenyl ether 
• 1612190-34-7 N-[2-hydroxy-3-(3-methoxyphenoxy)propyl]acetamide 
• 1612190-35-8 N-[2-hydroxy-3-(3-methoxyphenoxy)propyl]acrylamide 
• 1612190-36-9 N-[2-hydroxy-3-(3-methoxyphenoxy)propyl]benzamide 
• 1612190-37-0 N-[2-hydroxy-3-(3-methoxyphenoxy)propyl]-4-methoxybenzamide 
• 1433-08-5 anhydrovariabilin 
• 3172-99-4 Coumestrol dimethyl ether 

Relevant articles and documents

Substituted diaryl compound and preparation method and application thereof

The invention relates to the field of medicinal chemistry, in particular to a substituted diaryl compound (I). The preparation method comprises the following steps: medicine preparation and medical application thereof. Test results show that the substituted diaryl compound has a good inhibition effect on human lung cancer (A549), human ovarian cancer (SKOV3), human melanoma (A375) and human colon cancer (LOVO) cells. Formula (I):

Design, synthesis and biological evaluation of novel desloratadine derivatives with anti-inflammatory and H1 antagonize activities

To improve the anti-inflammatory activity of desloratadine, we designed and synthesized a series of novel desloratadine derivatives. All compounds were evaluated for their anti-inflammatory and H1 antagonistic activities. Among them, compound 2c showed the strongest H1 antagonistic and anti-inflammatory activity. It also exhibited promising pharmacokinetic profiles and low toxicity. All these results suggest that compound 2c as a novel anti-allergic agent is worthy of further investigation.

Syntheses of pterocarpenes and coumestans via regioselective cyclodehydration

A highly efficient synthetic route to pterocarpenes and coumestans is described. BCl3-mediated dehydrative cyclization of 1,3-diaryloxyacetones under mild conditions permitted regioselective ring closure to afford 3-((2-iodoaryloxy)methyl)benzo